Physician profile
Puja Patel
NPI 1043772031
$1,532.74
in general payments reported to CMS, 2019-2025
14 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $295 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.75 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $425.92 | 2024-2025 | Evenity, Tavneos, Prolia |
| Janssen Biotech, INC. | $340.00 | 2024-2025 | Tremfya |
| Abbvie INC. | $216.74 | 2024-2025 | |
| Pfizer INC. | $155.62 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.13 | 2025 | Jascayd, Ofev, Spevigo |
| Sobi, INC | $60.15 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $52.45 | 2025 | |
| Ani Pharmaceuticals, INC. | $38.60 | 2025 | Purified Cortrophin Gel |
| Ucb, INC. | $36.80 | 2025 | Bimzelx |
| Glaxosmithkline, LLC. | $36.12 | 2025 | Benlysta |
| Genzyme Corporation | $31.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.65 | 2025 | Orencia |
| Radius Health, INC. | $23.41 | 2025 | Tymlos |
| Organon LLC | $18.27 | 2025 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.